Rising Infectious Diseases Fueling Growth In The Anthrax Vaccine Market: Key Factor Driving The Growth In The Anthrax Vaccine Market

The Anthrax Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Anthrax Vaccine Market Size During the Forecast Period?
The anthrax vaccine market has grown strongly, expected to rise from $11.27 billion in 2024 to $11.88 billion in 2025 at a CAGR of 5.4%, driven by concerns around bioterrorism, military needs, disease outbreaks, public health strategies, and preparedness programs.

The anthrax vaccine market is forecast to rise to $14.5 billion in 2029 at a CAGR of 5.1%, supported by government security needs, pandemic readiness, and increased vaccine development, with trends focusing on next-gen vaccine innovations, accessibility, and collaborative research.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15511

What Are the High-Growth Segments in the Anthrax Vaccine Market?
The anthrax vaccine market covered in this report is segmented -

1) By Vaccine Type: Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine
2) By Application Type: Animal Use, Human Use
3) By Distribution Channel: Hospitals, Pharmacies, Other Distribution Channels

Subsegments:
1) By Cell-Free Protective Antigen (PA) Vaccine: Recombinant Protective Antigen (rPA) Vaccine, Adjuvanted rPA Vaccine
2) By Live Attenuated Vaccine: Live Attenuated Bacillus anthracis Vaccine, Genetically Modified Live Attenuated Vaccine

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15511&type=smp

What Key Drivers Are Expected to Influence Future Anthrax Vaccine Market Growth?
A surge in infectious diseases is promoting growth in the anthrax vaccine market. These illnesses, spread by pathogens, often result from urbanization, environmental changes, and population dynamics. While the anthrax vaccine primarily prevents anthrax, research is exploring its broader use due to its immune-boosting potential. In February 2023, the Council on Foreign Relations noted that 60% of known infectious diseases and 75% of emerging ones have zoonotic origins, causing 2.7 million deaths and 2.5 billion illness cases yearly. As such, the anthrax vaccine market is expanding due to infectious disease prevalence.

Which Companies Hold the Largest Share Across Different Anthrax Vaccine Market Segments?
Major companies operating in the anthrax vaccine market are Merck & Co. Inc., GC Biopharma, Emergent BioSolutions Inc., Indian Immunologicals Limited, Valneva SE, PharmAthene Inc., Porton Biopharma Limited, Pfenex Inc., Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company, Inc., Elusys Therapeutics Inc., SIGA Technologies Inc., Inovio Pharmaceuticals, Botswana Vaccine Institute, JOVAC, Prokarium, Soligenix Inc., Vaxart Inc., DynPort Vaccine Company LLC, VECOL S.A

What Are the Major Trends Shaping the Anthrax Vaccine Market?
Major companies in the anthrax vaccine market are prioritizing FDA-approved innovations to enhance safety and availability. In July 2023, Emergent BioSolutions Inc., a US-based biopharmaceutical company, secured FDA approval for CYFENDUS, an anthrax vaccine developed under the name AV7909. The vaccine demonstrated safety and strong immune response during Phase 2 and Phase 3 trials, aiming to reduce side effects and increase effectiveness.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anthrax-vaccine-global-market-report

What Are the Emerging Geographies for The Anthrax Vaccine Market Growth?
North America was the largest region in the anthrax vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthrax vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anthrax Vaccine Market?
2. What is the CAGR expected in the Anthrax Vaccine Market?
3. What Are the Key Innovations Transforming the Anthrax Vaccine Industry?
4. Which Region Is Leading the Anthrax Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.